Double-stranded (ds) RNA has diverse roles in host defense and disease prevention. dsRNA, produced by viral replication, elicits strong antiviral responses in host; similar protective responses can also be triggered by cellular dsRNA produced by necrotic, apoptotic, or otherwise stressed, uninfected cells. dsRNA is recognized in the cell by a large family of dsRNA-binding proteins, among which are the pattern recognition receptors (PRRs), toll-like receptor 3 (TLR3), and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs). TLR3 signals from the endosomal membrane where it senses extracellular dsRNA that has been endocytosed, whereas RLRs signal from the cytoplasm using a mitochondrial adaptor protein. In this review, we will summarize the signaling pathways used by these 2 PRRs, which lead to the activation of specific transcription factors and the induction of many proinflammatory and antiviral genes. However, it is becoming increasingly clear that all host responses are not mediated by the products of these induced genes; signal-dependent post-translational modifications of existing proteins can also profoundly change cellular properties. We will discuss how Src activation by TLR3 changes cell migration, adhesion, and proliferation rates and how IRF-3 activation by RLR triggers a gene induction-independent pro-apoptotic pathway that provides strong antiviral protection.
Get full access to this article
View all access options for this article.
References
1.
AllikmetsR, BergenAA, DeanM, GuymerRH, HagemanGS, KlaverCC, StefanssonK, WeberBH; International Age-related Macular Degeneration Genetics C. 2009. Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med, 360(21):2252–2254; author reply 2255–2256.
2.
BellJK, BotosI, HallPR, AskinsJ, ShiloachJ, SegalDM, DaviesDR. 2005. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A, 102(31):10976–10980.
3.
CastanoL, EisenbarthGS. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol, 8:647–679.
4.
ChattopadhyayS, FensterlV, ZhangY, VeleeparambilM, WetzelJL, SenGC. 2013a. Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators. MBio, 4(2):e00636.
5.
ChattopadhyayS, FensterlV, ZhangY, VeleeparambilM, YamashitaM, SenGC. 2013b. Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. J Virol, 87(1):16–24.
6.
ChattopadhyayS, MarquesJT, YamashitaM, PetersKL, SmithK, DesaiA, WilliamsBR, SenGC. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J, 29(10):1762–1773.
7.
ChattopadhyayS, SenGC. 2010. IRF-3 and Bax: a deadly affair. Cell Cycle, 9(13):2479–2480.
8.
ChattopadhyayS, YamashitaM, SenGC. 2012. Antiviral actions of double-stranded RNA. In: SambharaS, FujitaT, eds. Nucleic acid sensors and antiviral immunity. Austin (TX): Landes Bioscience. p 218–239.
9.
ChattopadhyayS, YamashitaM, ZhangY, SenGC. 2011. The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J Virol, 85(8):3708–3716.
10.
ChildsKS, RandallRE, GoodbournS. 2013. LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA. PLoS One, 8(5):e64202.
11.
ChiuYH, MacmillanJB, ChenZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell, 138(3):576–591.
12.
ChoeJ, KelkerMS, WilsonIA. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science, 309(5734):581–585.
13.
CuiS, EisenacherK, KirchhoferA, BrzozkaK, LammensA, LammensK, FujitaT, ConzelmannKK, KrugA, HopfnerKP. 2008. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol Cell, 29(2):169–179.
14.
DerSD, ZhouA, WilliamsBR, SilvermanRH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A, 95(26):15623–15628.
ElcoCP, GuentherJM, WilliamsBR, SenGC. 2005. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J Virol, 79(7):3920–3929.
18.
ErrettJS, SutharMS, McMillanA, DiamondMS, GaleMJr.2013. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol, 87(21):11416–11425.
19.
FengQ, HatoSV, LangereisMA, ZollJ, Virgen-SlaneR, PeisleyA, HurS, SemlerBL, van RijRP, van KuppeveldFJ. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep, 2(5):1187–1196.
20.
FitzgeraldKA, McWhirterSM, FaiaKL, RoweDC, LatzE, GolenbockDT, CoyleAJ, LiaoSM, ManiatisT. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol, 4(5):491–496.
GarciaM, DogusanZ, MooreF, SatoS, HartmannG, EizirikDL, RasschaertJ. 2009. Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells. Biochim Biophys Acta, 1793(11):1768–1775.
24.
GeissG, JinG, GuoJ, BumgarnerR, KatzeMG, SenGC. 2001. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem, 276(32):30178–30182.
25.
GitlinL, BarchetW, GilfillanS, CellaM, BeutlerB, FlavellRA, DiamondMS, ColonnaM. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A, 103(22):8459–8464.
26.
GitlinL, BenoitL, SongC, CellaM, GilfillanS, HoltzmanMJ, ColonnaM. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog, 6(1):e1000734.
27.
GouletML, OlagnierD, XuZ, PazS, BelgnaouiSM, LaffertyEI, JanelleV, ArguelloM, PaquetM, GhneimK, RichardsS, SmithA, WilkinsonP, CameronM, KalinkeU, QureshiS, LamarreA, HaddadEK, SekalyRP, PeriS, BalachandranS, LinR, HiscottJ. 2013. Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog, 9(4):e1003298.
28.
HartmannR, JustesenJ, SarkarSN, SenGC, YeeVC. 2003. Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase. Mol Cell, 12(5):1173–1185.
29.
HiscottJ. 2007. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem, 282(21):15325–15329.
30.
HornerSM, LiuHM, ParkHS, BrileyJ, GaleMJr.2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A, 108(35):14590–14595.
31.
HornungV, EllegastJ, KimS, BrzozkaK, JungA, KatoH, PoeckH, AkiraS, ConzelmannKK, SchleeM, EndresS, HartmannG. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science, 314(5801):994–997.
32.
HouF, SunL, ZhengH, SkaugB, JiangQX, ChenZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell, 146(3):448–461.
33.
KatoH, TakeuchiO, Mikamo-SatohE, HiraiR, KawaiT, MatsushitaK, HiiragiA, DermodyTS, FujitaT, AkiraS. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med, 205(7):1601–1610.
34.
KatoH, TakeuchiO, SatoS, YoneyamaM, YamamotoM, MatsuiK, UematsuS, JungA, KawaiT, IshiiKJ, YamaguchiO, OtsuK, TsujimuraT, KohCS, Reis e SousaC, MatsuuraY, FujitaT, AkiraS. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature, 441(7089):101–105.
35.
KawaiT, AkiraS. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci, 1143:1–20.
36.
KawaiT, AkiraS. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11(5):373–384.
37.
KawashimaT, KosakaA, YanH, GuoZ, UchiyamaR, FukuiR, KanekoD, KumagaiY, YouDJ, CarrerasJ, UematsuS, JangMH, TakeuchiO, KaishoT, AkiraS, MiyakeK, TsutsuiH, SaitoT, NishimuraI, TsujiNM. 2013. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-beta. Immunity, 38(6):1187–1197.
KumarH, KawaiT, KatoH, SatoS, TakahashiK, CobanC, YamamotoM, UematsuS, IshiiKJ, TakeuchiO, AkiraS. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med, 203(7):1795–1803.
40.
KumarH, KoyamaS, IshiiKJ, KawaiT, AkiraS. 2008. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol, 180(2):683–687.
41.
KuoRL, KaoLT, LinSJ, WangRY, ShihSR. 2013. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One, 8(5):e63431.
42.
LazearHM, PintoAK, RamosHJ, VickSC, ShresthaB, SutharMS, GaleMJr., DiamondMS. 2013. Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system. J Virol, 87(21):11401–11415.
43.
Le GofficR, PothlichetJ, VitourD, FujitaT, MeursE, ChignardM, Si-TaharM. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol, 178(6):3368–3372.
44.
LiY, ZhangX, PolakiewiczRD, YaoTP, CombMJ. 2008. HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem, 283(19):12686–12690.
45.
LooYM, FornekJ, CrochetN, BajwaG, PerwitasariO, Martinez-SobridoL, AkiraS, GillMA, Garcia-SastreA, KatzeMG, GaleMJr.2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol, 82(1):335–345.
46.
LooYM, GaleMJr.2011. Immune signaling by RIG-I-like receptors. Immunity, 34(5):680–692.
47.
MalathiK, DongB, GaleMJr., SilvermanRH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature, 448(7155):816–819.
48.
Martinez-GilL, GoffPH, HaiR, Garcia-SastreA, ShawML, PaleseP. 2013. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol, 87(3):1290–1300.
49.
McCartneySA, VermiW, LonardiS, RossiniC, OteroK, CalderonB, GilfillanS, DiamondMS, UnanueER, ColonnaM. 2011. RNA sensor-induced type I IFN prevents diabetes caused by a beta cell-tropic virus in mice. J Clin Invest, 121(4):1497–1507.
50.
MorescoEM, BeutlerB. 2010. LGP2: positive about viral sensing. Proc Natl Acad Sci U S A, 107(4):1261–1262.
51.
NakhaeiP, GeninP, CivasA, HiscottJ. 2009. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol, 21(4):215–222.
52.
OshiumiH, MiyashitaM, InoueN, OkabeM, MatsumotoM, SeyaT. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe, 8(6):496–509.
PetersK, ChattopadhyayS, SenGC. 2008. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol, 82(7):3500–3508.
55.
PetrasekJ, Iracheta-VellveA, CsakT, SatishchandranA, KodysK, Kurt-JonesEA, FitzgeraldKA, SzaboG. 2013. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A, 110(41):16544–16549.
56.
PichlmairA, SchulzO, TanCP, NaslundTI, LiljestromP, WeberF, Reis e SousaC. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science, 314(5801):997–1001.
57.
PoeckH, BscheiderM, GrossO, FingerK, RothS, RebsamenM, HannesschlagerN, SchleeM, RothenfusserS, BarchetW, KatoH, AkiraS, InoueS, EndresS, PeschelC, HartmannG, HornungV, RulandJ. 2010. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol, 11(1):63–69.
58.
RehwinkelJ, Reis e SousaC. 2010. RIGorous detection: exposing virus through RNA sensing. Science, 327(5963):284–286.
59.
RehwinkelJ, TanCP, GoubauD, SchulzO, PichlmairA, BierK, RobbN, VreedeF, BarclayW, FodorE, Reis e SousaC. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell, 140(3):397–408.
60.
ReinertLS, HarderL, HolmCK, IversenMB, HoranKA, Dagnaes-HansenF, UlhoiBP, HolmTH, MogensenTH, OwensT, NyengaardJR, ThomsenAR, PaludanSR. 2012. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest, 122(4):1368–1376.
SalaunB, ZitvogelL, Asselin-PaturelC, MorelY, CheminK, DuboisC, MassacrierC, ConfortiR, ChenardMP, SabourinJC, GoubarA, LebecqueS, PierresM, RimoldiD, RomeroP, AndreF. 2011. TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res, 71(5):1607–1614.
64.
SamuelCE. 2011. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology, 411(2):180–193.
65.
SarkarSN, ElcoCP, PetersKL, ChattopadhyayS, SenGC. 2007. Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation. J Biol Chem, 282(6):3423–3427.
66.
SarkarSN, PetersKL, ElcoCP, SakamotoS, PalS, SenGC. 2004. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol, 11(11):1060–1067.
67.
SatoM, SuemoriH, HataN, AsagiriM, OgasawaraK, NakaoK, NakayaT, KatsukiM, NoguchiS, TanakaN, TaniguchiT. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity, 13(4):539–548.
68.
SatohT, KatoH, KumagaiY, YoneyamaM, SatoS, MatsushitaK, TsujimuraT, FujitaT, AkiraS, TakeuchiO. 2010. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A, 107(4):1512–1517.
69.
SaundersLR, BarberGN. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J, 17(9):961–983.
70.
SenGC, SarkarSN. 2005. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev, 16(1):1–14.
71.
SethRB, SunL, EaCK, ChenZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, 122(5):669–682.
72.
SharmaS, tenOeverBR, GrandvauxN, ZhouGP, LinR, HiscottJ. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science, 300(5622):1148–1151.
73.
SherryB. 2009. Rotavirus and reovirus modulation of the interferon response. J Interferon Cytokine Res, 29(9):559–567.
74.
StrahleL, MarqJB, BriniA, HausmannS, KolakofskyD, GarcinD. 2007. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J Virol, 81(22):12227–12237.
75.
SunR, ZhangY, LvQ, LiuB, JinM, ZhangW, HeQ, DengM, LiuX, LiG, LiY, ZhouG, XieP, XieX, HuJ, DuanZ. 2011. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem, 286(18):15918–15928.
76.
SzeA, BelgnaouiSM, OlagnierD, LinR, HiscottJ, van GrevenyngheJ. 2013. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe, 14(4):422–434.
77.
TabetaK, GeorgelP, JanssenE, DuX, HoebeK, CrozatK, MuddS, ShamelL, SovathS, GoodeJ, AlexopoulouL, FlavellRA, BeutlerB. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A, 101(10):3516–3521.
78.
TormoD, ChecinskaA, Alonso-CurbeloD, Perez-GuijarroE, CanonE, Riveiro-FalkenbachE, CalvoTG, LarribereL, MegiasD, MuleroF, PirisMA, DashR, BarralPM, Rodriguez-PeraltoJL, Ortiz-RomeroP, TutingT, FisherPB, SoengasMS. 2009. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell, 16(2):103–114.
WiesE, WangMK, MaharajNP, ChenK, ZhouS, FinbergRW, GackMU. 2013. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity, 38(3):437–449.
84.
YamamotoM, SatoS, HemmiH, HoshinoK, KaishoT, SanjoH, TakeuchiO, SugiyamaM, OkabeM, TakedaK, AkiraS. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science, 301(5633):640–643.
YamashitaM, ChattopadhyayS, FensterlV, ZhangY, SenGC. 2012b. A TRIF-independent branch of TLR3 signaling. J Immunol, 188(6):2825–2833.
87.
YuM, LevineSJ. 2011. Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev, 22(2):63–72.
88.
ZengW, SunL, JiangX, ChenX, HouF, AdhikariA, XuM, ChenZJ. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell, 141(2):315–330.
89.
ZhangSY, HermanM, CiancanelliMJ, Perez de DiegoR, Sancho-ShimizuV, AbelL, CasanovaJL. 2013. TLR3 immunity to infection in mice and humans. Curr Opin Immunol, 25(1):19–33.
